Greenwich Lifesciences Inc GLSI:NASDAQ

RT Quote | USD
Last | 05/15/24 EDT
14.75quote price arrow up+1.11 (+8.14%)
Volume
23,798
52 week range
7.58 - 21.44
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.64
  • 52 Week High21.44
  • 52 Week High Date03/27/24
  • 52 Week Low7.58
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap189.957M
  • Shares Out12.88M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta3.33
  • YTD % Change40.21

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close13.64
  • 52 Week High21.44
  • 52 Week High Date03/27/24
  • 52 Week Low7.58
  • 52 Week Low Date10/26/23
  • Market Cap189.957M
  • Shares Out12.88M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta3.33
  • YTD % Change40.21

RATIOS/PROFITABILITY

  • EPS (TTM)-0.69
  • P/E (TTM)-21.31
  • Fwd P/E (NTM)-18.67
  • EBITDA (TTM)-9.324M
  • ROE (TTM)-89.30%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/22/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Greenwich Lifesciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Greenwich LifeSciences, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of GP2, immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. GP2 is a 9 amino acid transmembrane peptide of the human epidermal growth factor receptor 2 (HER2)/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 is delivered in combination with...
David Mcwilliams
Independent Chairman of the Board
Snehal Patel
Chief Executive Officer, Chief Financial Officer, Director
Jaye Thompson Ph.D.
Vice President - Clinical & Regulatory Affairs
Address
3992 Bluebonnet Dr, Building 14
Stafford, TX
77477
United States

Top Peers

SYMBOLLASTCHG%CHG
XFOR
X4 Pharmaceuticals Inc
0.9762-0.0092-0.9336%
ELEV
Elevation Oncology Inc
3.73+0.17+4.78%
DRTS
Alpha Tau Medical Ltd
2.65+0.02+0.61%
PROK
ProKidney Corp
3.92-0.20-4.85%
GOSS
Gossamer Bio Inc
0.7422+0.0094+1.2828%